Biocellvia

📍 Marseille, France🗓 Founded 2011👥 8 employees💰 Last funded Dec 2019
Biotechnology Research🌐 biocellvia.com
Website LinkedIn
Biocellvia is a french digital pathology company developing Intelligent Image Analysis solutions for pharmaceutical industry (Big Pharma, Biotechs, CRO) and academic communities involved in R&D. We have developed digital image analysis solutions, that enable to evaluate fully-automatically the level of efficacy of your lead molecules thanks to histological slides (in vitro, ex vivo, biopsies) in various pathologies such as: - Gastrointestinal (NASH, Liver fibrosis) - Respiratory (IPF, COPD, PAH) We provide image analysis as a service. Our technology evaluates your molecules with more accuracy, more reliability, more rapidity and less variability than traditional scoring methods. A full study (about 200 images) is performed in only a couple of days. http://biocellvia.com http://linkedin.com/company/biocellvia
1
Total investors
0
Early stage
0
Mid stage
1
Late stage
2011
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
1
Frequently asked questions
Who invested in Biocellvia?
Biocellvia has 1 investors on record on gritt.io and 1 late-stage investors.
When did Biocellvia last raise funding?
The most recent investment in Biocellvia recorded on gritt.io was in December 2019.
When was Biocellvia founded?
Biocellvia was founded in 2011.
What industry is Biocellvia in?
Biocellvia operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Biocellvia based?
Biocellvia is headquartered in Marseille, France.